David Linetsky - Feb 21, 2020 Form 4 Insider Report for Phreesia, Inc. (PHR)

Signature
/s/ Allison Hoffman by Power of Attorney for David Linetsky
Stock symbol
PHR
Transactions as of
Feb 21, 2020
Transactions value $
$2,491
Form type
4
Date filed
4/8/2025, 07:06 PM
Previous filing
Sep 10, 2021
Next filing
Sep 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHR Common Stock Options Exercise $2.49K +3.41K +1.58% $0.73 219K Feb 21, 2020 Direct F1, F2
transaction PHR Common Stock Award +6.43K +2.93% 226K Apr 4, 2025 Direct F2, F3
transaction PHR Common Stock Award +536 +6.14% 9.26K Apr 4, 2025 By Spouse F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHR Stock Option (Right to Buy) Options Exercise $0 -3.41K -100% $0.00 0 Feb 21, 2020 Common Stock 3.41K $0.73 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an option exercise that was not previously reported due to a vendor administrative oversight. Forms 4 filed after the date of exercise underreported total common stock holdings by 3,413 shares.
F2 The total in Column 5 has been adjusted to correct an overstatement of holdings by 2,298 shares first reflected in a Form 4 filed on May 5, 2021.
F3 Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025.
F4 This option was fully vested and exercisable as of the date of the reported transaction.